Evaluation of antimicrobial susceptibility patterns of enterococci isolated from patients in Tehran University of Medical Sciences teaching hospitals

Acta Medica Iranica

Volumn 47, Issue 4, 2009, Pages 325-328

  Jabalameli, Fereshteh ^a   Emaneini, Mohammad ^a   Shahsavan, Shadi ^a   Sedaghat, Hossein ^a   Abdolmaliki, Zohreh ^b   Aligholi, Marzieh ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF TEHRAN   (Iran)

Author keywords

Antimicrobial susceptibility patterns; Enterococci; Vancomycin resistant enterococci

Indexed keywords

AMPICILLIN; CEFAZOLIN; CIPROFLOXACIN; ERYTHROMYCIN; GENTAMICIN; PENICILLIN G; RIFAMPICIN; STREPTOMYCIN; TEICOPLANIN; VANCOMYCIN;

AGAR DILUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CONTROL STRATEGY; CONTROLLED STUDY; ENTEROCOCCUS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; GENOTYPE; HUMAN; IRAN; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; PRACTICE GUIDELINE; TEACHING HOSPITAL;

EID: 71849098426     PISSN: 00446025     EISSN: 00446025     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Cetinkaya Y, Falk P, Mayhall CG. Vancomycin-resistant enterococci. Clin Microbiol Rev 2000; 13(4): 686-707.
2. Schouten MA, Hoogkamp-Korstanje JA, Meis JF, Voss A; European VRE Study Group. Prevalence of vancomycin-resistant enterococci in Europe. Eur J Clin Microbiol Infect Dis 2000; 19(11): 816-822
3. Fatholahzadeh F, Hashemi FB, Emaneini M, Aligholi M, Nakhjavani FA, Kazemi B. Detection of Vancomycin resistant Enterococci (VRE) isolated from Urinary Tract Infections (UTI) in Tehran, Iran. Daru 2006; 14(3): 141-145 (Pubitemid 44808348)
4. Feizabadi MM, Asadi S, Aliahmadi A, Parvin M, Parastan R, Shayegh M, et al. Drug resistant patterns of enterococci recovered from patients in Tehran during 2000-2003. Int J Antimicrob Agents 2004; 24(5): 521-522
5. Udo EE, Al-Sweih N, Phillips OA, Chugh TD. Species prevalence and antibacterial resistance of enterococci isolated in Kuwait hospitals. J Med Microbiol 2003; 52(Pt 2): 163-168 (Pubitemid 36205265)
6. Murray BE. The life and times of the Enterococcus. Clin Microbiol Rev 1990; 3(1): 46-65.
7. Reinert RR, Conrads G, Schlaeger JJ, Werner G, Witte W, Lütticken R, et al. Survey of antibiotic resistance among enterococci in North Rhine-Westphalia, Germany. J Clin Microbiol 1999; 37(5): 1638-1641 (Pubitemid 29187859)
8. th ed. St. Louis, Missouri; Mosby; 1998.
9. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved Standard M7-A4. National Committee for Clinical Laboratory Standards (NCCLS): Wayne, PA, USA, 2004.
10. Dutka-Malen S, Evers S, Courvalin P. Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. J Clin Microbiol 1995; 33(1): 24-27 (Pubitemid 24382391)
11. Low DE, Keller N, Barth A, Jones RN. Clinical prevalence, antimicrobial susceptibility, and geographic resistance patterns of enterococci: results from the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis 2001; 32 Suppl 2: S133-45.
12. Edmond MB, Ober JF, Dawson JD, Weinbaum DL, Wenzel RP. Vancomycin-resistant enterococcal bacteremia: natural history and attributable mortality. Clin Infect Dis 1996; 23(6): 1234-1239
13. Jones RN, Sader HS, Erwin ME, Anderson SC. Emerging multiply resistant enterococci among clinical isolates. I. Prevalence data from 97 medical center surveillance study in the United States. Enterococcus Study Group. Diagn Microbiol Infect Dis 1995; 21(2): 85-93.
14. French GL. Enterococci and vancomycin resistance. Clin Infect Dis 1998; 27 Suppl 1: S75-83.
15. Zouain MG, Araj GF. Antimicrobial resistance of Enterococci in Lebanon. Int J Antimicrob Agents 2001; 17(3): 209-213
16. Udo EE, Al-Sweih N, John P, Chugh TD. Antibiotic resistance of enterococci isolated at a teaching hospital in Kuwait. Diagn Microbiol Infect Dis 2002; 43(3): 233-238 (Pubitemid 34775078)
17. Kaçmaz B, Aksoy A. Antimicrobial resistance of enterococci in Turkey. Int J Antimicrob Agents 2005; 25(6): 535-538
18. Titze-de-Almeida R, Rollo Filho M, Nogueira CA, Rodrigues IP, Eudes Filho J, Nascimento RS, et al. Molecular epidemiology and antimicrobial susceptibility of Enterococci recovered from Brazilian intensive care units. Braz J Infect Dis 2004; 8(3): 197-205.
19. Chaudhary U, Shamma M, Yadav A. Antimicrobial susceptibility patterns of common and unusual enterococcus species isolated from clinical specimens. J Infect Dis Antimicrob Agents 2007; 24: 55-62.
20. Hryniewicz W, Zareba T, Kawalec M. Susceptibility patterns of Enterococcus spp. isolated in Poland during 1996. Int J Antimicrob Agents 1998; 10(4): 303-307
21. Udo EE, Al-Sweih N, John P, Jacob LE, Mohanakrishnan S. Characterization of high-level aminoglycoside-resistant enterococci in Kuwait hospitals. Microb Drug Resist 2004; 10(2): 139-145 (Pubitemid 38879014)
22. Feizabadi MM, Maleknejad P, Asgharzadeh A, Asadi S, Shokrzadeh L, Sayadi S. Prevalence of aminoglycoside-modifying enzymes genes among isolates of Enterococcus faecalis and Enterococcus faecium in Iran. Microb Drug Resist 2006; 12(4): 265-268 (Pubitemid 46106698)
23. del Campo R, Tenorio C, Rubio C, Castillo J, Torres C, Gómez-Lus R. Aminoglycoside-modifying enzymes in high-level streptomycin and gentamicin resistant Enterococcus spp. in Spain. Int J Antimicrob Agents 2000; 15(3): 221-226 (Pubitemid 30645472)
24. Emaneini M, Hashemi FB, Aligholi M, Fatholahzadeh B, Kazemi B, Sadeghi F. Detection of vanB genotype enterococci in Iran. Int J Antimicrob Agents 2005; 26(1): 98-99 (Pubitemid 40854128)